Be Biopharma grabs $52m Series A
Be Biopharma, a developer of B cells as medicines, has secured $52 million in Series A financing.
Be Biopharma, a developer of B cells as medicines, has secured $52 million in Series A financing.
Copyright PEI Media
Not for publication, email or dissemination